January 31, 2015 11:55 PM ET

Healthcare Providers and Services

Company Overview of EKR Therapeutics, Inc.

Company Overview

As of June 26, 2012, EKR Therapeutics, Inc. was acquired by Cornerstone Therapeutics Inc. EKR Therapeutics, Inc. operates as a specialty pharmaceutical company and identifies, commercializes, and markets products to acute-care hospitals. The company offers acute-care and oncology supportive care therapeutic products, including nicardipine hydrochloride, morphine sulfate extended-release liposome injection, and reteplase, recombinant. It serves hospital administrators and healthcare providers in the United States. The company was founded in 2005 and is based in Bedminster, New Jersey.

1545 US Highway 206

3rd Floor

Bedminster, NJ 07921

United States

Founded in 2005

Phone:

877-435-2524

Fax:

866-457-0803

Key Executives for EKR Therapeutics, Inc.

EKR Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Centre for Neuro Skills United States
WES Corporation United States
Trans-Century Resources Inc. United States
Carolina Behavioral Services, Llc United States
Good Keep International Ltd. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EKR Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.